Target-Directed Approaches for Screening Small Molecules against RNA Targets.
Haniff HS, Knerr L, Chen JL, Disney MD, Lightfoot HL.
SLAS Discov. 2020 Sep;25(8):869-894. doi: 10.1177/2472555220922802. Epub 2020 May 18.
Target-directed catalytic metallodrugs.
Joyner JC, Cowan JA.
Braz J Med Biol Res. 2013 Jun;46(6):465-85. doi: 10.1590/1414-431X20133086. Epub 2013 Jul 2.
Chasing molecular glue degraders: screening approaches.
Domostegui A, Nieto-Barrado L, Perez-Lopez C, Mayor-Ruiz C.
Chem Soc Rev. 2022 Jul 4;51(13):5498-5517. doi: 10.1039/d2cs00197g.
Synthetic Lethality in Cancer Therapeutics: The Next Generation.
Setton J, Zinda M, Riaz N, Durocher D, Zimmermann M, Koehler M, Reis-Filho JS, Powell SN.
Cancer Discov. 2021 Jul;11(7):1626-1635. doi: 10.1158/2159-8290.CD-20-1503. Epub 2021 Apr 1.
The Osteosarcoma Microenvironment: A Complex But Targetable Ecosystem.
Corre I, Verrecchia F, Crenn V, Redini F, Trichet V.
Cells. 2020 Apr 15;9(4):976. doi: 10.3390/cells9040976.
Strategies for targeting undruggable targets.
Zhang G, Zhang J, Gao Y, Li Y, Li Y.
Expert Opin Drug Discov. 2022 Jan;17(1):55-69. doi: 10.1080/17460441.2021.1969359. Epub 2021 Aug 30.
Genome engineering with zinc-finger nucleases.
Carroll D.
Genetics. 2011 Aug;188(4):773-82. doi: 10.1534/genetics.111.131433.
Targeting thromboinflammation in antiphospholipid syndrome.
Salet DM, Bekkering S, Middeldorp S, van den Hoogen LL.
J Thromb Haemost. 2023 Apr;21(4):744-757. doi: 10.1016/j.jtha.2022.12.002. Epub 2022 Dec 22.
Artificial Intelligence Teaches Drugs to Target Proteins by Tackling the Induced Folding Problem.
Fernández A.
Mol Pharm. 2020 Aug 3;17(8):2761-2767. doi: 10.1021/acs.molpharmaceut.0c00470. Epub 2020 Jul 7.
Emerging Target Families: Intractable Targets.
Knapp S.
Handb Exp Pharmacol. 2016;232:43-58. doi: 10.1007/164_2015_28.
